Carbamazepine-associated encephalopathy can be differentiated against
more frequent toxic symptoms by its occurrence at low plasma levels. S
ymptomatology consists of disorientation, somnolence and increasing se
izure frequency together with background showing generalised high and
voltage theta-delta-activity in the electroencephalogram. In all repor
ted cases, symptoms disappeared rapidly and completely after the withd
rawal of carbamazepine. No abnormal laboratory parameters have been ab
served. The cause of the encephalopathy ist still unclear. Especially
hyponatremia which is occasionally associated with encephalopathic sym
ptoms and which results from the interaction of carbamazepine with the
antidiuretic hormone (ADH) receptor was never reported in carbamazepi
ne encephalopathy. In addition to two cases published during the last
decade, we report on two further patients with carbamazepine encephalo
pathy.